La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « Wai Kin D. Ko »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
W. Wieling < Wai Kin D. Ko < Waljit S. Dhillo  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000015 (2016-07-13) Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Yang Jianzhong [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [Royaume-Uni]An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000050 (2016) Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie]Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000051 (2016) Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Jianzhong Yang [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [France]An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000059 (2015) Sandrine Camus [Royaume-Uni] ; Wai Kin D. Ko [Royaume-Uni] ; Elsa Pioli [Royaume-Uni] ; Erwan Bezard [France]Why bother using non-human primate models of cognitive disorders in translational research?
000072 (2015) Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000104 (2014-04-30) Wai Kin D. Ko [Royaume-Uni] ; Qin Li [République populaire de Chine] ; Erwan Bezard [France]Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease.
000112 (2014) Wai Kin D. Ko [France] ; Marie-Laure Martin-Negrier [France] ; Erwan Bezard [France] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni]RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Animals
3Antiparkinson Agents (adverse effects)
3Levodopa (adverse effects)
2Antiparkinson Agents (pharmacology)
2Disease Models, Animal
2Dyskinesia, Drug-Induced (physiopathology)
2Humans
2Levodopa (pharmacology)
2Male
2Parkinson Disease (drug therapy)
2Rats, Sprague-Dawley
1Alzheimer Disease (physiopathology)
1Antiparkinson Agents (administration & dosage)
1Behavior, Animal (drug effects)
1Brain (physiopathology)
1Cells, Cultured
1Central Nervous System (drug effects)
1Central Nervous System (physiopathology)
1Cognition Disorders (genetics)
1Cognition Disorders (physiopathology)
1Corpus Striatum (drug effects)
1Corpus Striatum (physiopathology)
1Drug Therapy, Combination
1Dyskinesia, Drug-Induced (drug therapy)
1Dyskinesia, Drug-Induced (prevention & control)
1Dyskinesia, Drug-Induced (therapy)
1Enkephalins (metabolism)
1Female
1Functional Laterality
1Gene Expression (drug effects)
1Genetic Therapy
1Levodopa (administration & dosage)
1Macaca
1Macaca fascicularis
1Oligonucleotides, Antisense (administration & dosage)
1Oxidopamine
1Parkinson Disease (physiopathology)
1Parkinsonian Disorders (drug therapy)
1Parkinsonian Disorders (physiopathology)
1Piperazines (administration & dosage)
1Piperazines (pharmacology)
1Primates
1Protein Precursors (metabolism)
1Pyrimidines (administration & dosage)
1Pyrimidines (pharmacology)
1RGS Proteins (genetics)
1RGS Proteins (metabolism)
1RNA, Messenger (metabolism)
1Rats
1Serotonin Receptor Agonists (administration & dosage)
1Serotonin Receptor Agonists (pharmacology)
1Species Specificity
1Translational Medical Research (methods)
1Triazoles (administration & dosage)
1Triazoles (pharmacology)
1Up-Regulation (drug effects)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Wai Kin D. Ko" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Wai Kin D. Ko" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Wai Kin D. Ko
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024